TC BioPharm (NASDAQ:TCBP) stock is falling on Wednesday after the clinical-stage biopharmaceutical company announced the pricing of a registered direct offering of its shares. TC BioPharm is selling 2 million of its American Depository Shares (ADS) for $1 per share. This has the company expecting gross proceeds of $2 million from this offering. To go along with this, the company is offering warrants for 2 million shares of TCBP stock to a single investor. These are Series G warrants that are exercisable onl ...